Qing Ling Yu
Vorstandsvorsitzender bei Beijing Advaccine Biotechnology Co., Ltd.
Profil
Qing Ling Yu is currently the President, General Manager & Executive Director at Beijing Advaccine Biotechnology Co., Ltd.
Prior to this, she obtained an undergraduate degree from the University of International Business & Economics in 2001.
Aktive Positionen von Qing Ling Yu
| Unternehmen | Position | Beginn |
|---|---|---|
Beijing Advaccine Biotechnology Co., Ltd.
 Beijing Advaccine Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Advaccine Biotechnology Co., Ltd. engages in the research and development of prophylactic and therapeutic vaccines. Its pipeline focuses on the treatment of diseases caused by SARS-CoV-2, respiratory syncytial virus, and hepatitis B virus. The company was founded by Bin Wang in April 2009 and is headquartered in Suzhou, China. | Vorstandsvorsitzender | 08.04.2009 |
Ausbildung von Qing Ling Yu
| University of International Business & Economics | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
 | Health Technology |
